| Product Code: ETC11387148 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Netherlands saw a shift in antibiotics import sources in 2024, with Italy, Estonia, Germany, Austria, and India emerging as top exporters. The market experienced a decrease in concentration levels from high to moderate, indicating increased diversification. The compound annual growth rate (CAGR) over the period 2020-2024 stood at 1.91%, with the growth rate for 2023-2024 matching this figure. This steady growth and changing trade patterns suggest a dynamic market landscape and potential opportunities for market players in the antibiotics import sector in the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Antibiotics Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Antibiotics Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Antibiotics Market - Industry Life Cycle |
3.4 Netherlands Antibiotics Market - Porter's Five Forces |
3.5 Netherlands Antibiotics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Netherlands Antibiotics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Antibiotics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Netherlands Antibiotics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Antibiotics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases |
4.2.2 Growing awareness about the overuse of antibiotics and the rise of antibiotic resistance |
4.2.3 Technological advancements in antibiotic research and development |
4.3 Market Restraints |
4.3.1 Stringent regulations on antibiotic use and prescription |
4.3.2 Increasing preference for alternative therapies and natural remedies |
4.3.3 High cost associated with development and production of new antibiotics |
5 Netherlands Antibiotics Market Trends |
6 Netherlands Antibiotics Market, By Types |
6.1 Netherlands Antibiotics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Antibiotics Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Netherlands Antibiotics Market Revenues & Volume, By Beta-Lactams, 2021 - 2031F |
6.1.4 Netherlands Antibiotics Market Revenues & Volume, By Macrolides, 2021 - 2031F |
6.1.5 Netherlands Antibiotics Market Revenues & Volume, By Tetracyclines, 2021 - 2031F |
6.2 Netherlands Antibiotics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Antibiotics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Netherlands Antibiotics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Netherlands Antibiotics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Antibiotics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Netherlands Antibiotics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Netherlands Antibiotics Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Netherlands Antibiotics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Antibiotics Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.4.3 Netherlands Antibiotics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4.4 Netherlands Antibiotics Market Revenues & Volume, By Online, 2021 - 2031F |
7 Netherlands Antibiotics Market Import-Export Trade Statistics |
7.1 Netherlands Antibiotics Market Export to Major Countries |
7.2 Netherlands Antibiotics Market Imports from Major Countries |
8 Netherlands Antibiotics Market Key Performance Indicators |
8.1 Number of reported cases of antibiotic-resistant infections |
8.2 Investment in research and development of new antibiotics |
8.3 Adoption rate of alternative therapies in place of antibiotics |
9 Netherlands Antibiotics Market - Opportunity Assessment |
9.1 Netherlands Antibiotics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Netherlands Antibiotics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Antibiotics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Netherlands Antibiotics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Antibiotics Market - Competitive Landscape |
10.1 Netherlands Antibiotics Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Antibiotics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |